Nomura Holdings Inc. Purchases New Position in McKesson Co. (NYSE:MCK)

Nomura Holdings Inc. purchased a new stake in shares of McKesson Co. (NYSE:MCK) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 4,179 shares of the company’s stock, valued at approximately $2,382,000.

A number of other hedge funds also recently bought and sold shares of the business. Millstone Evans Group LLC purchased a new position in shares of McKesson during the 4th quarter worth approximately $28,000. Synergy Asset Management LLC purchased a new position in shares of McKesson during the 4th quarter worth approximately $32,000. Crews Bank & Trust purchased a new position in shares of McKesson during the 4th quarter worth approximately $33,000. Atala Financial Inc purchased a new position in shares of McKesson during the 4th quarter worth approximately $34,000. Finally, Graney & King LLC purchased a new position in shares of McKesson during the 4th quarter worth approximately $38,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

McKesson Stock Performance

Shares of McKesson stock opened at $723.05 on Friday. McKesson Co. has a one year low of $464.42 and a one year high of $728.48. The stock’s fifty day moving average is $683.14 and its 200 day moving average is $626.73. The stock has a market cap of $90.62 billion, a P/E ratio of 33.11, a P/E/G ratio of 1.29 and a beta of 0.53.

McKesson (NYSE:MCK) last announced its earnings results on Thursday, May 8th. The company reported $10.12 EPS for the quarter, topping analysts’ consensus estimates of $9.83 by $0.29. McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. The company had revenue of $90.82 billion for the quarter, compared to analysts’ expectations of $94 billion. During the same period last year, the firm earned $6.18 EPS. McKesson’s revenue for the quarter was up 18.9% compared to the same quarter last year. Analysts predict that McKesson Co. will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 2nd will be issued a $0.71 dividend. The ex-dividend date is Monday, June 2nd. This represents a $2.84 dividend on an annualized basis and a yield of 0.39%. McKesson’s dividend payout ratio is currently 10.99%.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Mizuho upped their price target on McKesson from $630.00 to $690.00 and gave the stock a “neutral” rating in a research note on Thursday, April 3rd. Wells Fargo & Company upped their price target on McKesson from $641.00 to $691.00 and gave the stock an “equal weight” rating in a research note on Friday, March 14th. Bank of America upped their price target on McKesson from $755.00 to $800.00 and gave the stock a “buy” rating in a research note on Friday, May 9th. Morgan Stanley upped their price target on McKesson from $642.00 to $745.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 2nd. Finally, StockNews.com upgraded McKesson from a “buy” rating to a “strong-buy” rating in a research note on Tuesday. Three investment analysts have rated the stock with a hold rating, eleven have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $686.69.

Insider Buying and Selling

In other McKesson news, CEO Brian S. Tyler sold 8,961 shares of the firm’s stock in a transaction dated Friday, February 21st. The stock was sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the sale, the chief executive officer now directly owns 60,664 shares of the company’s stock, valued at $36,276,465.36. This trade represents a 12.87% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.11% of the stock is owned by insiders.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.